JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
SLN Financials - Silence Therapeutics Income & Cash Flow | Ledgeburg
SLN - Silence Therapeutics PLC
USD | NASDAQ | Healthcare
Summary
Summary SLN Stock
Financials
Financials SLN Stock
Loading...
Loading...
Income Statement
Income Statement SLN Stock
Balance Sheet
Balance Sheet SLN Stock
Cash Flow Statement
Cash Flow Statement SLN Stock
Loading...
Loading...
Home
Stocks
Silence Therapeutics PLC (SLN)
Financials
Financials of SLN
Loading...
Loading...
Loading...
Loading...
Revenue
$559K
Operating Income
$-91.077M
Net Income
$-88.612M
Share Count (Basic)
141.694702M
Operating Cash Flow
$-62.271M
Free Cash Flow
$-62.326M
Cash And Short-Term Equivalents
$85.114M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
10M
20M
30M
40M
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
100K
200K
300K
400K
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-90M
-80M
-70M
-60M
-50M
Annual
Quarterly
Margins
Gross
Operating
Net
-15000%
-10000%
-5000%
0%
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-30M
-25M
-20M
-15M
-10M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-40000%
-30000%
-20000%
-10000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26